Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 452606, 21 pages
http://dx.doi.org/10.1155/2011/452606
Review Article

Profile of a Serial Killer: Cellular and Molecular Approaches to Study Individual Cytotoxic T-Cells following Therapeutic Vaccination

1Department of Research, University Hospital Center (CHUV) and University of Lausanne (UNIL), c/o HO, Niv 5, Labo 1532, Avenue Pierre-Decker 4, 1011 Lausanne, Switzerland
2Ludwig Institute for Cancer Research Ltd., University Hospital Center (CHUV) and University of Lausanne (UNIL), c/o HO, Niv 5, Labo 1552, Avenue Pierre-Decker 4, 1011 Lausanne, Switzerland

Received 30 August 2010; Accepted 29 September 2010

Academic Editor: James L. Gulley

Copyright © 2011 Emanuela M. Iancu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. Lasithiotakis, I. E. Petrakis, and C. Garbe, “Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment,” Melanoma Research, vol. 20, no. 3, pp. 163–170, 2010. View at Publisher · View at Google Scholar · View at PubMed
  2. T. Boon, P. G. Coulie, B. J. Van Den Eynde, and P. Van Der Bruggen, “Human T cell responses against melanoma,” Annual Review of Immunology, vol. 24, pp. 175–208, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. D. E. Speiser, D. Liénard, and D. Liénard, “In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells,” European Journal of Immunology, vol. 32, no. 3, pp. 731–741, 2002. View at Google Scholar · View at Scopus
  4. D. Liénard, D. Rimoldi, and D. Rimoldi, “Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA,” Cancer Immunity, vol. 4, p. 4, 2004. View at Google Scholar · View at Scopus
  5. P. Romero, P. R. Dunbar, and P. R. Dunbar, “Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes,” Journal of Experimental Medicine, vol. 188, no. 9, pp. 1641–1650, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Romero, D. Valmori, and D. Valmori, “Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma,” Immunological Reviews, vol. 188, pp. 81–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Dutoit, V. Rubio-Godoy, and V. Rubio-Godoy, “Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-A peptide multimer+CD8+ T cells in humans,” Journal of Experimental Medicine, vol. 196, no. 2, pp. 207–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Zippelius, M. J. Pittet, and M. J. Pittet, “Thymic selection generates a large T cell pool recognizing a self-peptide in humans,” Journal of Experimental Medicine, vol. 195, no. 4, pp. 485–494, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Beutler, “Inferences, questions and possibilities in Toll-like receptor signalling,” Nature, vol. 430, no. 6996, pp. 257–263, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. N. Germain, “An innately interesting decade of research in immunology,” Nature Medicine, vol. 10, no. 12, pp. 1307–1320, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, pp. 197–216, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. E. Speiser, D. Liénard, and D. Liénard, “Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 739–746, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. E. Speiser, P. Baumgaertner, V. Voelter, E. Devevre, C. Barbey, N. Rufer, and P. Romero, “Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 10, pp. 3849–3854, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. E. Dudley, J. R. Wunderlich, and J. R. Wunderlich, “Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes,” Science, vol. 298, no. 5594, pp. 850–854, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. E. Dudley, J. R. Wunderlich, and J. R. Wunderlich, “Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma,” Journal of Clinical Oncology, vol. 23, no. 10, pp. 2346–2357, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. D. Altman, P. A. H. Moss, and P. A. H. Moss, “Phenotypic analysis of antigen-specific T lymphocytes,” Science, vol. 274, no. 5284, pp. 94–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Klenerman, V. Cerundolo, and P. R. Dunbar, “Tracking T cells with tetramers: new tales from new tools,” Nature Reviews Immunology, vol. 2, no. 4, pp. 263–272, 2002. View at Google Scholar · View at Scopus
  19. L. Derré, C. Jandus, P. Baumgaertner, V. Posevitz, E. Devêvre, P. Romero, and D. E. Speiser, “Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses,” Methods in Molecular Biology, vol. 626, pp. 231–249, 2010. View at Publisher · View at Google Scholar
  20. M. Volkert, O. Marker, and K. Bro-Jorgensen, “Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus,” Journal of Experimental Medicine, vol. 139, no. 5, pp. 1329–1343, 1974. View at Google Scholar · View at Scopus
  21. R. Ahmed and D. Gray, “Immunological memory and protective immunity: understanding their relation,” Science, vol. 272, no. 5258, pp. 54–60, 1996. View at Google Scholar · View at Scopus
  22. F. Sallusto, D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia, “Two subsets of memory T lymphocytes with distinct homing potentials and effector functions,” Nature, vol. 401, no. 6754, pp. 708–712, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. F. Sallusto, J. Geginat, and A. Lanzavecchia, “Central memory and effector memory T cell subsets: function, generation, and maintenance,” Annual Review of Immunology, vol. 22, pp. 745–763, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. Sallusto, B. Palermo, A. Hoy, and A. Lanzavecchia, “The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells,” Current Topics in Microbiology and Immunology, vol. 246, pp. 123–129, 1999. View at Google Scholar · View at Scopus
  25. G. M. A. Gillespie, M. R. Wills, and M. R. Wills, “Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors,” Journal of Virology, vol. 74, no. 17, pp. 8140–8150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson, “EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function,” Journal of Immunology, vol. 167, no. 4, pp. 2019–2029, 2001. View at Google Scholar · View at Scopus
  27. P. Champagne, G. S. Ogg, and G. S. Ogg, “Skewed maturation of memory HIV-specific CD8 T lymphocytes,” Nature, vol. 410, no. 6824, pp. 106–111, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. L. E. Gamadia, R. J. Rentenaar, and R. J. Rentenaar, “Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers,” Blood, vol. 98, no. 3, pp. 754–761, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Appay, P. R. Dunbar, and P. R. Dunbar, “Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections,” Nature Medicine, vol. 8, no. 4, pp. 379–385, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. Papagno, C. A. Spina, and C. A. Spina, “Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection,” PLoS Biology, vol. 2, no. 2, article no. E20, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. H. Tomiyama, H. Takata, T. Matsuda, and M. Takiguchi, “Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function,” European Journal of Immunology, vol. 34, no. 4, pp. 999–1010, 2004. View at Publisher · View at Google Scholar · View at PubMed
  32. N. Rufer, A. Zippelius, and A. Zippelius, “Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions,” Blood, vol. 102, no. 5, pp. 1779–1787, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. Monteiro, C. Evaristo, A. Legrand, A. Nicoletti, and B. Rocha, “Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression,” Blood, vol. 109, no. 7, pp. 2863–2870, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. P. Romero, A. Zippelius, and A. Zippelius, “Four functionally distinct populations of human effector-memory CD8+ T lymphocytes,” Journal of Immunology, vol. 178, no. 7, pp. 4112–4119, 2007. View at Google Scholar · View at Scopus
  35. A. D. Hislop, N. E. Annels, N. H. Gudgeon, A. M. Leese, and A. B. Rickinson, “Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection,” Journal of Experimental Medicine, vol. 195, no. 7, pp. 893–905, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Chen, P. Shankar, and P. Shankar, “CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection,” Blood, vol. 98, no. 1, pp. 156–164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Khan, M. Cobbold, R. Keenan, and P. A. H. Moss, “Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype,” Journal of Infectious Diseases, vol. 185, no. 8, pp. 1025–1034, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. R. Wills, G. Okecha, M. P. Weekes, M. K. Gandhi, P. J. G. Sissons, and A. J. Carmichael, “Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T cell response,” Journal of Immunology, vol. 168, no. 11, pp. 5455–5464, 2002. View at Google Scholar · View at Scopus
  39. B. Rocha and C. Tanchot, “The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends,” Immunological Reviews, vol. 211, pp. 182–196, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. Wiesel, S. Walton, K. Richter, and A. Oxenius, “Virus-specific CD8 T cells: activation, differentiation and memory formation,” Acta Pathologica, Microbiologica. et Immunologica Scandinavica, vol. 117, no. 5-6, pp. 356–381, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. P. K. Chattopadhyay and M. Roederer, “Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease,” Cytometry Part A, vol. 77, no. 7, pp. 614–622, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. D. E. Speiser, M. Migliaccio, and M. Migliaccio, “Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells,” European Journal of Immunology, vol. 31, no. 2, pp. 459–466, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. E. M. Iancu, P. Corthesy, and P. Corthesy, “Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time,” Journal of Immunology, vol. 183, no. 1, pp. 319–331, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. C. Touvrey, L. Derré, E. Devevre, P. Corthesy, P. Romero, N. Rufer, and D. E. Speiser, “Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase,” Journal of Immunology, vol. 182, no. 11, pp. 6718–6726, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. E. Speiser, P. Baumgaertner, and P. Baumgaertner, “A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination,” Journal of Immunology, vol. 177, no. 2, pp. 1338–1348, 2006. View at Google Scholar · View at Scopus
  46. L. Derré, M. Ferber, and M. Ferber, “A novel population of human melanoma-specific CD8 T cells recognizes melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide,” Journal of Immunology, vol. 179, no. 11, pp. 7635–7645, 2007. View at Google Scholar · View at Scopus
  47. C. Barbey, P. Baumgaertner, and P. Baumgaertner, “IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells,” Journal of Immunology, vol. 178, no. 6, pp. 3566–3574, 2007. View at Google Scholar · View at Scopus
  48. L. Derré, M. Bruyninx, and M. Bruyninx, “In vivo persistence of codominant human CD8+ T cell clonotypes is not limited by replicative senescence or functional alteration,” Journal of Immunology, vol. 179, no. 4, pp. 2368–2379, 2007. View at Google Scholar · View at Scopus
  49. L. Derré, M. Bruyninx, and M. Bruyninx, “Distinct sets of αβ TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 39, pp. 15010–15015, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. V. Appay, C. Jandus, and C. Jandus, “New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site,” Journal of Immunology, vol. 177, no. 3, pp. 1670–1678, 2006. View at Google Scholar · View at Scopus
  51. S. Wieckowski, P. Baumgaertner, P. Corthesy et al., “Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients,” The Journal of Immunology, vol. 183, pp. 5397–5406, 2009. View at Google Scholar
  52. V. Voelter, A. Pica, and A. Pica, “An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain,” Cancer Immunity, vol. 8, p. 6, 2008. View at Google Scholar · View at Scopus
  53. P. K. Chattopadhyay, M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa, “The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression,” Journal of Leukocyte Biology, vol. 85, no. 1, pp. 88–97, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. F. Sallusto and A. Lanzavecchia, “Exploring pathways for memory T cell generation,” Journal of Clinical Investigation, vol. 108, no. 6, pp. 805–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Lanzavecchia and F. Sallusto, “Understanding the generation and function of memory T cell subsets,” Current Opinion in Immunology, vol. 17, no. 3, pp. 326–332, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. A. V. Gett, F. Sallusto, A. Lanzavecchia, and J. Geginat, “T cell fitness determined by signal strength,” Nature Immunology, vol. 4, no. 4, pp. 355–360, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. F. Bachmann, P. Wolint, K. Schwarz, and A. Oxenius, “Recall proliferation potential of memory CD8+ T cells and antiviral protection,” Journal of Immunology, vol. 175, no. 7, pp. 4677–4685, 2005. View at Google Scholar · View at Scopus
  58. A. D. Roberts, K. H. Ely, and D. L. Woodland, “Differential contributions of central and effector memory T cells to recall responses,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 123–133, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. E. J. Wherry, V. Teichgräber, and V. Teichgräber, “Lineage relationship and protective immunity of memory CD8T cell subsets,” Nature Immunology, vol. 4, no. 3, pp. 225–234, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. E. W. Newell, L. O. Klein, W. Yu, and M. M. Davis, “Simultaneous detection of many T-cell specificities using combinatorial tetramer staining,” Nature Methods, vol. 6, no. 7, pp. 497–499, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. S. R. Hadrup, A. H. Bakker, and A. H. Bakker, “Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers,” Nature Methods, vol. 6, no. 7, pp. 520–526, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. M. Ayyoub, D. Dojcinovic, P. Pignon, I. Raimbaud, J. Schmidt, I. Luescher, and D. Valmori, “Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 16, pp. 7437–7442, 2010. View at Publisher · View at Google Scholar · View at PubMed
  63. G. Makedonas, N. Hutnick, and N. Hutnick, “Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8+ T cells,” PLoS Pathogens, vol. 6, no. 3, article no. e1000798, 2010. View at Publisher · View at Google Scholar · View at PubMed
  64. K. T. Brunner, J. Mauel, J. C. Cerottini, and B. Chapuis, “Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs,” Immunology, vol. 14, no. 2, pp. 181–196, 1968. View at Google Scholar · View at Scopus
  65. M. J. Pittet, V. Rubio-Godoy, and V. Rubio-Godoy, “α3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells,” Journal of Immunology, vol. 171, no. 4, pp. 1844–1849, 2003. View at Google Scholar · View at Scopus
  66. L. Zaritskaya, M. R. Shurin, T. J. Sayers, and A. M. Malyguine, “New flow cytometric assays for monitoring cell-mediated cytotoxicity,” Expert Review of Vaccines, vol. 9, no. 6, pp. 601–616, 2010. View at Publisher · View at Google Scholar · View at PubMed
  67. M. R. Betts, J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup, “Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation,” Journal of Immunological Methods, vol. 281, no. 1-2, pp. 65–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Devêvre, P. Romero, and Y. D. Mahnke, “LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry,” Journal of Immunological Methods, vol. 311, no. 1-2, pp. 31–46, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. V. Appay, D. E. Speiser, and D. E. Speiser, “Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide,” European Journal of Immunology, vol. 36, no. 7, pp. 1805–1814, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. V. Rubio-Godoy, V. Dutoit, and V. Dutoit, “Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL,” Journal of Immunology, vol. 169, no. 10, pp. 5696–5707, 2002. View at Google Scholar · View at Scopus
  71. N. Rufer, W. Dragowska, G. Thornbury, E. Roosnek, and P. M. Lansdorp, “Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry,” Nature Biotechnology, vol. 16, no. 8, pp. 743–747, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. N. Rufer, T. H. Brümmendorf, and T. H. Brümmendorf, “Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood,” Journal of Experimental Medicine, vol. 190, no. 2, pp. 157–167, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. D. M. Baird, J. Rowson, D. Wynford-Thomas, and D. Kipling, “Extensive allelic variation and ultrashort telomeres in senescent human cells,” Nature Genetics, vol. 33, no. 2, pp. 203–207, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. E. M. Iancu, D. E. Speiser, and N. Rufer, “Assessing ageing of individual T lymphocytes: mission impossible?” Mechanisms of Ageing and Development, vol. 129, no. 1-2, pp. 67–78, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. D. C. Douek, R. D. McFarland, and R. D. McFarland, “Changes in thymic function with age and during the treatment of HIV infection,” Nature, vol. 396, no. 6712, pp. 690–695, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. R. J. Critchley-Thorne, N. Yan, S. Nacu, J. Weber, S. P. Holmes, and P. P. Lee, “Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.,” PLoS Medicine, vol. 4, no. 5, article no. e176, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. O. D. Perez, D. Mitchell, and D. Mitchell, “Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1,” Nature Immunology, vol. 4, no. 11, pp. 1083–1092, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. I. Kuss, H. Rabinowich, W. Gooding, R. Edwards, and T. L. Whiteside, “Expression of ζ in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma,” Cancer Biotherapy and Radiopharmaceuticals, vol. 17, no. 6, pp. 631–640, 2002. View at Google Scholar · View at Scopus
  79. T. L. Whiteside, “Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?” Cancer Immunology, Immunotherapy, vol. 53, no. 10, pp. 865–878, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. P. R. Dunbar, C. L. Smith, and C. L. Smith, “A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response,” Journal of Immunology, vol. 165, no. 11, pp. 6644–6652, 2000. View at Google Scholar · View at Scopus
  81. R. Mortarini, A. Piris, and A. Piris, “Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma,” Cancer Research, vol. 63, no. 10, pp. 2535–2545, 2003. View at Google Scholar · View at Scopus
  82. A. Zippelius, P. Batard, and P. Batard, “Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance,” Cancer Research, vol. 64, no. 8, pp. 2865–2873, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Ahmadzadeh, L. A. Johnson, B. Heemskerk, J. R. Wunderlich, M. E. Dudley, D. E. White, and S. A. Rosenberg, “Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired,” Blood, vol. 114, no. 8, pp. 1537–1544, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. M. Ahmadzadeh, A. Felipe-Silva, B. Heemskerk, D. J. Powell Jr., J. R. Wunderlich, M. J. Merino, and S. A. Rosenberg, “FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions,” Blood, vol. 112, no. 13, pp. 4953–4960, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. M. Beyer, J. Karbach, and J. Karbach, “Cancer vaccine enhanced, non-tumor-reactive CD8+ T cells exhibit a distinct molecular program associated with "division arrest anergy",” Cancer Research, vol. 69, no. 10, pp. 4346–4354, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. N. Rufer, “Molecular tracking of antigen-specific T-cell clones during immune responses,” Current Opinion in Immunology, vol. 17, no. 4, pp. 441–447, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. V. Appay, A. Bosio, and A. Bosio, “Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages,” Journal of Immunology, vol. 179, no. 11, pp. 7406–7414, 2007. View at Google Scholar · View at Scopus
  88. N. Rufer, P. Reichenbach, and P. Romero, “Methods for the ex vivo characterization of human CD8+ T subsets based on gene expression and replicative history analysis,” Methods in Molecular Medicine, vol. 109, pp. 265–284, 2005. View at Google Scholar · View at Scopus
  89. A. Peixoto, M. Monteiro, B. Rocha, and H. Veiga-Fernandes, “Quantification of multiple gene expression in individual cells,” Genome Research, vol. 14, no. 10, pp. 1938–1947, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. A. Peixoto, C. Evaristo, I. Munitic, M. Monteiro, A. Charbit, B. Rocha, and H. Veiga-Fernandes, “CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response,” Journal of Experimental Medicine, vol. 204, no. 5, pp. 1193–1205, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. S. Esumi, S.-X. Wu, Y. Yanagawa, K. Obata, Y. Sugimoto, and N. Tamamaki, “Method for single-cell microarray analysis and application to gene-expression profiling of GABAergic neuron progenitors,” Neuroscience Research, vol. 60, no. 4, pp. 439–451, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. F. C. Fiesel, A. Voigt, and A. Voigt, “Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6,” The EMBO Journal, vol. 29, no. 1, pp. 209–221, 2010. View at Publisher · View at Google Scholar · View at PubMed
  93. J. Waak, S. S. Weber, and S. S. Weber, “Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1,” FASEB Journal, vol. 23, no. 8, pp. 2478–2489, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. M. Alunni-Fabbroni and M. T. Sandri, “Circulating tumour cells in clinical practice: methods of detection and possible characterization,” Methods, vol. 50, no. 4, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at PubMed
  95. V. Mayer, U. Schoen, E. Holinski-Feder, U. Koehler, and S. Thalhammer, “Single cell analysis of mutations in the APC gene,” Fetal Diagnosis and Therapy, vol. 26, pp. 148–156, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. D. Woide, V. Mayer, T. Wachtmeister, N. Hoehn, A. Zink, U. Koehler, and S. Thalhammer, “Single particle adsorbing transfer system,” Biomedical Microdevices, vol. 11, no. 3, pp. 609–614, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. S. Lutz-Bonengel, T. Sänger, and T. Sänger, “Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmic,” International Journal of Legal Medicine, vol. 122, no. 3, pp. 189–197, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. T. Kroneis, L. Gutstein-Abo, and L. Gutstein-Abo, “Automatic retrieval of single microchimeric cells and verification of identity by on-chip multiplex PCR,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 954–969, 2010. View at Publisher · View at Google Scholar · View at PubMed
  99. N. E. Holodick, K. Repetny, X. Zhong, and T. L. Rothstein, “Adult BM generates CD5+ B1 cells containing abundant N-region additions,” European Journal of Immunology, vol. 39, no. 9, pp. 2383–2394, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. C. Pannetier, J. Even, and P. Kourilsky, “T-cell repertoire diversity and clonal expansions in normal and clinical samples,” Immunology Today, vol. 16, no. 4, pp. 176–181, 1995. View at Publisher · View at Google Scholar · View at Scopus
  101. E. Roux, C. Helg, F. Dumont-Girard, B. Chapuis, M. Jeannet, and E. Roosnek, “Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts,” Blood, vol. 87, no. 9, pp. 3984–3992, 1996. View at Google Scholar
  102. S. J. Turner, K. Kedzierska, N. L. La Gruta, R. Webby, and P. C. Doherty, “Characterization of CD8+ T cell repertoire diversity and persistence in the influenza a virus model of localized, transient infection,” Seminars in Immunology, vol. 16, no. 3, pp. 179–184, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. J. L. Maryanski, C. V. Jongeneel, P. Bucher, J.-L. Casanova, and P. R. Walker, “Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones,” Immunity, vol. 4, no. 1, pp. 47–55, 1996. View at Publisher · View at Google Scholar · View at Scopus
  104. S. J. Turner, G. Diaz, R. Cross, and P. C. Doherty, “Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response,” Immunity, vol. 18, no. 4, pp. 549–559, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Kedzierska, S. J. Turner, and P. C. Doherty, “Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4942–4947, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. S. M. Kaech and E. J. Wherry, “Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection,” Immunity, vol. 27, no. 3, pp. 393–405, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. E. J. Wherry, S.-J. Ha, and S.-J. Ha, “Molecular signature of CD8+ T cell exhaustion during chronic viral infection,” Immunity, vol. 27, no. 4, pp. 670–684, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. C. Stemberger, K. M. Huster, M. Koffler, F. Anderl, M. Schiemann, H. Wagner, and D. H. Busch, “A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets,” Immunity, vol. 27, no. 6, pp. 985–997, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. K. Kedzierska, V. Venturi, K. Field, M. P. Davenport, S. J. Turner, and P. C. Doherty, “Early establishment of diverse T cell receptor profiles for influenza-specific CD8+CD62Lhi memory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9184–9189, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. C. Bouneaud, Z. Garcia, P. Kourilsky, and C. Pannetier, “Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo,” Journal of Experimental Medicine, vol. 201, no. 4, pp. 579–590, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. V. Baron, C. Bouneaud, and C. Bouneaud, “The repertoires of circulating human CD8+ central and effector memory T cell subsets are largely distinct,” Immunity, vol. 18, no. 2, pp. 193–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. M.-P. Lefranc, V. Giudicelli, and V. Giudicelli, “IMGT, the international ImMunoGeneTics database,” Nucleic Acids Research, vol. 27, no. 1, pp. 209–212, 1999. View at Publisher · View at Google Scholar
  113. D. C. Douek, M. R. Betts, and M. R. Betts, “A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape,” Journal of Immunology, vol. 168, no. 6, pp. 3099–3104, 2002. View at Google Scholar
  114. D. A. Price, T. E. Asher, and T. E. Asher, “Public clonotype usage identifies protective gag-specific CD8+ t cell responses in SIV infection,” Journal of Experimental Medicine, vol. 206, no. 4, pp. 923–936, 2009. View at Publisher · View at Google Scholar · View at PubMed
  115. V. Venturi, Y. C. Hui, D. A. Price, D. C. Douek, and M. P. Davenport, “The role of production frequency in the sharing of simian immunodeficiency virus-specific CD8+ TCRs between macaques,” Journal of Immunology, vol. 181, no. 4, pp. 2597–2609, 2008. View at Google Scholar
  116. D. A. Price, S. M. West, and S. M. West, “T cell receptor recognition motifs govern immune escape patterns in acute SIV infection,” Immunity, vol. 21, no. 6, pp. 793–803, 2004. View at Publisher · View at Google Scholar · View at PubMed
  117. M. Z. Smith, T. E. Asher, V. Venturi, M. P. Davenport, D. C. Douek, D. A. Price, and S. J. Kent, “Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge,” Journal of Virology, vol. 82, no. 15, pp. 7357–7368, 2008. View at Publisher · View at Google Scholar · View at PubMed
  118. J. R. Almeida, D. A. Price, and D. A. Price, “Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover,” Journal of Experimental Medicine, vol. 204, no. 10, pp. 2473–2485, 2007. View at Publisher · View at Google Scholar · View at PubMed
  119. K. L. Schaubert, D. A. Price, and D. A. Price, “Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes,” European Journal of Immunology, vol. 40, no. 7, pp. 1950–1962, 2010. View at Publisher · View at Google Scholar · View at PubMed
  120. J. R. Almeida, D. Sauce, and D. Sauce, “Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity,” Blood, vol. 113, no. 25, pp. 6351–6360, 2009. View at Publisher · View at Google Scholar · View at PubMed
  121. C. Geldmacher, I. S. Metzler, and I. S. Metzler, “Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response,” Blood, vol. 114, no. 8, pp. 1553–1562, 2009. View at Publisher · View at Google Scholar · View at PubMed
  122. K. L. Schaubert, D. A. Price, and D. A. Price, “Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope,” Journal of Immunology, vol. 178, no. 12, pp. 7756–7766, 2007. View at Google Scholar
  123. J. Kan-Mitchell, M. Bajcz, and M. Bajcz, “Degeneracy and repertoire of the human HIV-1 Gag p1777-85 CTL response,” Journal of Immunology, vol. 176, no. 11, pp. 6690–6701, 2006. View at Google Scholar
  124. V. Venturi, H. Y. Chin, and H. Y. Chin, “TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV,” Journal of Immunology, vol. 181, no. 11, pp. 7853–7862, 2008. View at Google Scholar
  125. D. A. Price, J. M. Brenchley, and J. M. Brenchley, “Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses,” Journal of Experimental Medicine, vol. 202, no. 10, pp. 1349–1361, 2005. View at Publisher · View at Google Scholar · View at PubMed
  126. D. K. Cole, E. S. Edwards, K. K. Wynn et al., “Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition,” The Journal of Immunology, vol. 185, pp. 2600–2610, 2010. View at Google Scholar
  127. D. K. Cole, F. Yuan, and F. Yuan, “Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor,” Journal of Biological Chemistry, vol. 284, no. 40, pp. 27281–27289, 2009. View at Publisher · View at Google Scholar · View at PubMed
  128. J. J. Melenhorst, P. Scheinberg, and P. Scheinberg, “High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow,” Blood, vol. 113, no. 10, pp. 2238–2244, 2009. View at Publisher · View at Google Scholar · View at PubMed
  129. L. Trautmann, M. Rimbert, and M. Rimbert, “Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses,” Journal of Immunology, vol. 175, no. 9, pp. 6123–6132, 2005. View at Google Scholar
  130. V. Venturi, K. Kedzierska, D. A. Price, P. C. Doherty, D. C. Douek, S. J. Turner, and M. P. Davenport, “Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 49, pp. 18691–18696, 2006. View at Publisher · View at Google Scholar · View at PubMed
  131. V. Venturi, D. A. Price, D. C. Douek, and M. P. Davenport, “The molecular basis for public T-cell responses?” Nature Reviews Immunology, vol. 8, no. 3, pp. 231–238, 2008. View at Publisher · View at Google Scholar · View at PubMed
  132. P.-Y. Dietrich, F.-A. Le Gal, and F.-A. Le Gal, “Prevalent role of TCR α-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen,” Journal of Immunology, vol. 170, no. 10, pp. 5103–5109, 2003. View at Google Scholar
  133. L. Trautmann, N. Labarrière, and N. Labarrière, “Dominant TCR Vα usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens,” European Journal of Immunology, vol. 32, no. 11, pp. 3181–3190, 2002. View at Google Scholar
  134. F. Serana, A. Sottini, L. Caimi, B. Palermo, P. G. Natali, P. Nisticò, and L. Imberti, “Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients,” Journal of Translational Medicine, vol. 7, article no. 21, 2009. View at Publisher · View at Google Scholar · View at PubMed
  135. H. Uchi, R. Stan, and R. Stan, “Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo,” Advances in Immunology, vol. 90, pp. 215–241, 2006. View at Publisher · View at Google Scholar · View at PubMed
  136. T. M. Clay, M. C. Custer, and M. C. Custer, “Changes in the fine specificity of gp100((209–217))-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue,” Journal of Immunology, vol. 162, no. 3, pp. 1749–1755, 1999. View at Google Scholar
  137. T. B. Stuge, S. P. Holmes, S. Saharan, A. Tuettenberg, M. Roederer, J. S. Weber, and P. P. Lee, “Diversity and recognition efficiency of T cell responses to cancer,” PLoS Medicine, vol. 1, no. 2, article no. e28, 2004. View at Google Scholar
  138. F.-A. Le Gal, M. Ayyoub, and M. Ayyoub, “Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1,” Journal of Immunotherapy, vol. 28, no. 3, pp. 252–257, 2005. View at Google Scholar
  139. G. M. Bendle, J. B. Haanen, and T. N. Schumacher, “Preclinical development of T cell receptor gene therapy,” Current Opinion in Immunology, vol. 21, no. 2, pp. 209–214, 2009. View at Publisher · View at Google Scholar · View at PubMed
  140. L. A. Johnson, R. A. Morgan, and R. A. Morgan, “Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen,” Blood, vol. 114, no. 3, pp. 535–546, 2009. View at Publisher · View at Google Scholar · View at PubMed
  141. D. A. Schmid, M. B. Irving, and M. B. Irving, “Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function,” Journal of Immunology, vol. 184, no. 9, pp. 4936–4946, 2010. View at Publisher · View at Google Scholar · View at PubMed
  142. M. Dougan and G. Dranoff, “Immune therapy for cancer,” Annual Review of Immunology, vol. 27, pp. 83–117, 2009. View at Publisher · View at Google Scholar · View at PubMed